Drug industry marketing, a long controversial aspect of a physicians' practice and life, may perhaps be experiencing its tightest guidelines yet. Dr. Joseph Heyman, chair of the American Medical Association board of trustees, tells host Bruce Japsen about his thoughts on the new voluntary pharmaceutical industry guidelines on marketing and gift-giving to physicians, signifynig a departure from prior practices.
Thoughts on New Pharma Marketing Guidelines
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Drug industry marketing, a long controversial aspect of a physicians' practice and life, may perhaps be experiencing its tightest guidelines yet. Dr. Joseph Heyman, chair of the American Medical Association board of trustees, tells host Bruce Japsen about his thoughts on the new voluntary pharmaceutical industry guidelines on marketing and gift-giving to physicians, signifynig a departure from prior practices.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?